tetano
Editor, Senior Moderator
J Med Pract Manage. 2010 Nov-Dec;26(3):182-7.
Improving influenza vaccine distribution in preparation for an H1N1 influenza pandemic: lessons from the field.
Wahlen MK, Bessette RR, Bernard ME, Springer DJ, Benson CA.
Department of Family Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Abstract
Vaccine distribution is an essential component of any healthcare organization's pandemic influenza plan. Variables surrounding distribution in these circumstances are often difficult to anticipate and require careful consideration. The 2009 H1N1 influenza pandemic provided organizations with an opportunity to test current models and overall organizational readiness for the next influenza pandemic. This article describes the experiences at a large, midwestern, multispecialty medical system in responding to the unique circumstances surrounding distribution of the 2009 H1N1 influenza vaccine. We discuss challenges, variables to consider when choosing a vaccine distribution model, institutional response, and lessons learned.
PMID: 21243892 [PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/21243892
Improving influenza vaccine distribution in preparation for an H1N1 influenza pandemic: lessons from the field.
Wahlen MK, Bessette RR, Bernard ME, Springer DJ, Benson CA.
Department of Family Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Abstract
Vaccine distribution is an essential component of any healthcare organization's pandemic influenza plan. Variables surrounding distribution in these circumstances are often difficult to anticipate and require careful consideration. The 2009 H1N1 influenza pandemic provided organizations with an opportunity to test current models and overall organizational readiness for the next influenza pandemic. This article describes the experiences at a large, midwestern, multispecialty medical system in responding to the unique circumstances surrounding distribution of the 2009 H1N1 influenza vaccine. We discuss challenges, variables to consider when choosing a vaccine distribution model, institutional response, and lessons learned.
PMID: 21243892 [PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/21243892